Article

Neurochemical Research

, 31:361

First online:

Binding of 3H-WIN-35,428 and 125I-RTI-121 to Human Platelet Membranes

  • Donatella MarazzitiAffiliated withDipartimento di Psichiatria, Neurobiologia, Farmacologia e Biotecnologie, University of PisaDipartimento di Psichiatria, Neurobiologia, Farmacologia e Biotecnologie, University of Pisa Email author 
  • , Stefano BaroniAffiliated withDipartimento di Psichiatria, Neurobiologia, Farmacologia e Biotecnologie, University of Pisa
  • , Laura FabbriniAffiliated withDipartimento di Psichiatria, Neurobiologia, Farmacologia e Biotecnologie, University of Pisa
  • , Paola ItalianiAffiliated withDipartimento di Psichiatria, Neurobiologia, Farmacologia e Biotecnologie, University of Pisa
  • , Mario CatenaAffiliated withDipartimento di Psichiatria, Neurobiologia, Farmacologia e Biotecnologie, University of Pisa
  • , Bernardo Dell’OssoAffiliated withDipartimento di Psichiatria, Neurobiologia, Farmacologia e Biotecnologie, University of Pisa
  • , Laura BettiAffiliated withDipartimento di Psichiatria, Neurobiologia, Farmacologia e Biotecnologie, University of Pisa
  • , Gino GiannacciniAffiliated withDipartimento di Psichiatria, Neurobiologia, Farmacologia e Biotecnologie, University of Pisa
  • , Antonio LucacchiniAffiliated withDipartimento di Psichiatria, Neurobiologia, Farmacologia e Biotecnologie, University of Pisa
    • , Giovanni B. CassanoAffiliated withDipartimento di Psichiatria, Neurobiologia, Farmacologia e Biotecnologie, University of Pisa

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Abstract

The dopamine transporter (DAT) is a protein regulating dopamine concentration in the synaptic cleft through the re-uptake mechanism. The DAT is the main target of psychostimulants and seems to play a pivotal role in neuronal degeneration and different neuropsychiatric disorders involving the dopamine system. Exhaustive research, however, regarding the presence of this protein in human platelets is still inconclusive, although it is thought that it might provide a peripheral tool to serve as a mean of exploring the same structure present in the brain. Therefore, we assessed some binding assays in platelets derived from healthy human subjects by means of 3H-WIN 35,428, a compound which is considered a selective ligand for the labelling of this protein, and by means of 125I-RTI-121, another compound with high specificity for DAT. The results showed that the binding of 3H-WIN-35,428 was too low to enable the detection of any structure; the binding of 125I-RTI-121, on the other hand, revealed the presence of two binding sites with pharmacological profiles similar to that of the serotonin transporter (SERT). In conclusions, therefore, platelets would not seem to be a useful model for exploring the DAT, given the prevalence therein of the SERT and the difficulty of labelling the DAT with the currently available ligands.

Keywords

Dopamine Transporter (DAT) Serotonin Transporter (SERT) human platelets 3H-WIN 35,428 125I-RTI-121